• JP Insurance net income forecast misses estimates and predicts a net income of 79.00 billion yen against an estimate of 85.26 billion yen.
• JP Insurance also predicts lower net sales at 5.96 trillion yen compared to the estimated 6.15 trillion yen.
• Interestingly, the company sees a higher dividend of 104.00 yen which is more favourable than the estimated 97.17 yen.
• Despite the missed forecast, the fourth quarter results show a net income of 21.90 billion yen, higher than the estimated 12.8 billion yen indicating a strong quarterly performance.
• The predictive scores stand at 3 buys, 5 holds, and 1 sell implying varying analyst outlooks regarding the company’s stock performance.
A look at Japan Post Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Japan Post Insurance demonstrates a strong long-term outlook as per the Smartkarma Smart Scores assessment. With a top score in Value and Resilience, the company is positioned well in terms of its financial health and stability. This signifies that Japan Post Insurance is considered to be a solid investment option with attractive valuation metrics and a resilient business model.
While showing slightly lower scores in Growth, Dividend, and Momentum, Japan Post Insurance still maintains a favorable overall outlook. The company’s portfolio of life insurance products catering to various needs of individuals and businesses across Japan reflects its diversified revenue streams and stable market presence. This suggests that Japan Post Insurance may offer consistent returns to investors over the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
